Jason Duncan, Chief Legal Officer and GC at ALBIREO PHARMA, INC. (ALBO), sold 938 shares at $43.90 ($41K) on 2023-01-19, disclosed to the SEC on 2023-01-20.
Scheduled sale ($41k) by Chief Legal Officer and GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALBO | SELL | 2022-07-25 | $16K | — | Filing → |
| ALBO | SELL | 2022-04-25 | $22K | — | Filing → |
| ALBO | SELL | 2022-01-25 | $42K | — | Filing → |